NEW YORK, NY / ACCESSWIRE / September 8, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
JCOM Shareholders Click Here: https://www.zlk.com/pslra-1/j2-global-inc-loss-submission-form?prid=9099&wire=1
STAA Shareholders Click Here: https://www.zlk.com/pslra-1/staar-surgical-company-information-request-form?prid=9099&wire=1
PLAN Shareholders Click Here: https://www.zlk.com/pslra-1/anaplan-inc-information-request-form?prid=9099&wire=1
* ADDITIONAL INFORMATION BELOW *
J2 Global, Inc. (NASDAQ:JCOM)
JCOM Lawsuit on behalf of: investors who purchased October 5, 2015 - June 29, 2020
Lead Plaintiff Deadline : September 8, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/j2-global-inc-loss-submission-form?prid=9099&wire=1
According to the filed complaint, during the class period, J2 Global, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) J2 Global engaged in undisclosed related party transactions; (2) J2 Global used misleading accounting to hide requisite impairments and underperformance in acquisitions; (3) several so-called independent members of the Company' board of directors and audit committee were not disinterested; and (4) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.
Staar Surgical Company (NASDAQ:STAA)
STAA Lawsuit on behalf of: investors who purchased February 26, 2020 - August 10, 2020
Lead Plaintiff Deadline : October 19, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/staar-surgical-company-information-request-form?prid=9099&wire=1
According to the filed complaint, during the class period, Staar Surgical Company made materially false and/or misleading statements and/or failed to disclose that: the Company was overstating and/or mischaracterizing: (1) its sales and growth in China; (2) its marketing spend; (3) its research and development expenses; and that as a result of the foregoing, (4) Defendants' public statements were materially false and misleading at all relevant times.
Anaplan Inc. (NYSE:PLAN)
PLAN Lawsuit on behalf of: investors who purchased November 21, 2019 - February 26, 2020
Lead Plaintiff Deadline : October 23, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/anaplan-inc-information-request-form?prid=9099&wire=1
According to the filed complaint, during the class period, Anaplan Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was undergoing sales organization and execution challenges; (2) these organizational challenges were causing the Company to miss on closing very important large deals; and (3) as a result, Anaplan's financial guidance for "calculated billings growth" was baseless and unattainable. Further, while in possession of this material non-public information, Anaplan insiders dumped approximately $30 million worth of Anaplan stock at artificially inflated prices.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
SOURCE: Levi & Korsinsky, LLP